Franklin Saumell
General Practice · Miami, FLNPI 1154457398
Payments from drug & device makers
What this record shows
That places this record below the midpoint for general practice clinicians in FL, where the typical reported total is $253.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$1,116,980in research payments, 2019–2025
Across 259 payments — averaging $4312.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$850K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$135K
- Avanir Pharmaceuticals, Inc.$88K
- Sanofi$38K
- Boehringer Ingelheim International GmbH$5K
- Bausch Health US, LLC$1K
How this compares
$0 in reported general payments places this provider in the 0th percentile of 6,901 general practice providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 16 | $68 |
Paid to pharmacies, not to this prescriber.
Other general practice in Miami
- Idalia AcostaMiami$99K
- Eddie GomezMiami$59K
- Aladino ValienteMiami$24K
- Viviana WaichMiami$20K
- Libia RiosMiami$15K
- Jose CardonaMiami$15K
- Rosa HuguetMiami$15K
- Robert VogelPalm Beach Gardens$1M
- Bruce OuelletteWest Palm Beach$724K
- Caley CasteleinMiami Beach$586K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.